This early-stage study tests a new vaccine (AVX70371) designed to treat chronic hepatitis B. Researchers will give the vaccine to 16 healthy adults aged 18 to 40 to check its safety and how well it triggers an immune response. The goal is to see if the vaccine can help the body f…
Phase: PHASE1 • Sponsor: AstriVax Therapeutics • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 29, 2026 15:02 UTC